Further research using immunohistochemical staining of CCL28 in the lesional AD skin and other cutaneous hypersensitivities are warranted as well as studies addressing the relations between its expression and the conventional lines of treatment used. This evidence concerns the gene CCL28 and Alzheimer disease.